Skip to main content
search
Poster

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Skip to PDF content

Authors: Certara: Daniela S. Santurio, Aiman A. Nazki, Sirin Yonucu, Birses Debir, Maciej Swat, Rachel Rose, Piet H. van der Graaf, Andrzej M. Kierzek in collaboration with Universiteit Leiden, The Netherlands and the School of Biosciences University of Surrey

See How Virtual Patients Can Improve Development Decisions

Explore how QSP platforms such as IO Simulator can help predict treatment outcomes, evaluate safety risks, optimize combination therapies, and support patient-centered development strategies in oncology and beyond.

View Our Quantitative Systems Pharmacology Services

You May Also Like

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate DevelopmentAnnouncement

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling
Machine Learning-Based Covariate Selection for Population Pharmacokinetic ModelingPoster

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices
Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practicesPoster

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices